---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-26-000048"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2026-07-30T20:09:48+00:00"
generated_at: "2026-07-30T20:11:39.386836+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stryker Q2 2026: net sales $6.6B (+9.4%), adj EPS $3.69 (+17.9%), narrows FY guidance

## Summary
- Q2 net sales $6.6B, up 9.4% reported and 9.0% organic; MedSurg/Neuro +9.2% organic, Orthopaedics +8.6%.
- Reported EPS $3.30 (+44.1%), adjusted EPS $3.69 (+17.9%); adjusted operating margin 27.4% (+170 bps).
- FY 2026 guidance narrowed: organic sales growth 8.3%-9.3%, adjusted EPS $14.95-$15.10.
- CEO cites recovery from cyber incident and strong execution; momentum regained.

## SEC filing metadata
- accession: 0000310764-26-000048
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2026-07-30T20:09:48+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/0000310764-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076426000048/syk-20260730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-26-000048
- JSON: https://secwatch.observer/filing/0000310764-26-000048.json
- Plain text: https://secwatch.observer/filing/0000310764-26-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.